FDA Staff Recommends Rejection Of Chelsea's Northera

Posted on February 21, 2012 at 18:25 PM EST

Food and Drug Administration staff recommended denial of approval for Chelsea Therapeutics International Ltd.'s (Nasdaq: CHTP) hypotension treatment Northera sending the stock price tumbling 71 cents to close at $2.64.

Related Stocks:

Chelsea Therapeutics International Ltd.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Mortgage Rates, CD Rates & Home Equity Rates provided by Banks.com
Press Release Service provided by PRConnect.
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Postage Rates